The use of fatty acid biomarkers to reflect dietary intake
- 1 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 17 (1), 22-27
- https://doi.org/10.1097/01.mol.0000199814.46720.83
Abstract
This review compares fatty acid biomarkers to assess compliance in dietary intervention trials with their application in epidemiological studies. Although many studies have used fatty acid biomarkers to assess compliance in short-term dietary intervention trials and habitual diets in observational studies, there is little information on the reliability and comparability of these measures. In this review, we summarize the usefulness and limitations of fatty acid biomarkers in clinical and epidemiological studies. As there are very few recent publications in this area, a complete literature review is provided. Several options are available for the biological assessment of dietary fatty acids. The type of study (short or long-term), the metabolic characteristics and expected variability in the fatty acids of interest are major considerations when determining which tissues reflect a better measure of true intake. Certain fatty acids may not be suitable to assess differences in intake under non-isocaloric conditions and when trying to identify small differences. Serum cholesterol ester is the most suitable serum fraction to assess short-term dietary compliance, but given the multiple factors that affect response, the quantification of compliance should be interpreted with caution. Adipose tissue is the biomarker of choice for long-term intake, but a preferred blood constituent (plasma versus erythrocytes) is difficult to establish given the data available to date. Future studies should explore the use of whole blood as an alternative choice to measure fatty acid intake in epidemiological studies.Keywords
This publication has 39 references indexed in Scilit:
- Fasting Whole Blood as a Biomarker of Essential Fatty Acid Intake in Epidemiologic Studies: Comparison with Adipose Tissue and PlasmaAmerican Journal of Epidemiology, 2005
- Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Polyunsaturated Fatty Acids May Impair Blood Glucose Control in Type 2 Diabetic PatientsDiabetic Medicine, 1992
- Effect of a Diet Enriched with Monounsaturated or Polyunsaturated Fatty Acids on Levels of Low-Density and High-Density Lipoprotein Cholesterol in Healthy Women and MenNew England Journal of Medicine, 1989
- Effect of Dietary Stearic Acid on Plasma Cholesterol and Lipoprotein LevelsNew England Journal of Medicine, 1988
- Similar serum lipoprotein reductions by lipid-lowering diets with different polyunsaturated:saturated fat valuesBritish Journal of Nutrition, 1983
- The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: Salmon oil versus vegetable oilsMetabolism, 1983
- Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol Reduction of the proportion of linoleate by clofibrate but not by niceritrolAtherosclerosis, 1980
- Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acidsJournal of Clinical Investigation, 1969
- Effect of Dietary Fats on Fatty Acid Composition of Human Erythrocytes and Chick CerebellaScience, 1959